CDC announces new childhood vaccine recommendations, suggesting fewer shots
Washington — The Centers For Disease Control and Prevention (CDC) has recently released updated recommendations for childhood vaccines, sparking debate among doctors and public health experts. The new guidelines propose a reduction in the number of shots required for children, from 17 immunizations to 11.
The revised recommendations now include vaccinations for diseases such as diphtheria, tetanus, acellular pertussis (whooping cough), Haemophilus influenzae type b (Hib), Pneumococcal conjugate, polio, measles, mumps, rubella, human papillomavirus (HPV), and varicella (chickenpox). The CDC suggests that only children in high-risk categories receive vaccinations for respiratory syncytial virus (RSV), hepatitis A, hepatitis B, dengue, meningococcal ACWY, and meningococcal B.
For children not classified as high-risk, the decision to administer certain vaccines, such as COVID-19, influenza, meningococcal disease, hepatitis A, and hepatitis B, should be made through shared clinical decision-making between physicians and parents.
One of the most controversial changes in the new guidelines is the delay in administering the first dose of the hepatitis B vaccine. Previously recommended within 24 hours of birth, the CDC now advises waiting until a child reaches 2 months old if born to mothers who test negative for the virus. This shift, endorsed by the CDC’s vaccine advisory panel appointed by Secretary of Health Robert F. Kennedy Jr., has stirred mixed reactions.
Kennedy, a prominent vaccine critic, praised the new guidelines for prioritizing child safety, honoring family choices, and rebuilding public trust in healthcare. He emphasized the alignment of the U.S. childhood vaccine schedule with international standards, highlighting transparency and informed consent as key principles.
A comparative analysis conducted by the Health and Human Services Department revealed that the U.S. stands out as a “global outlier” in terms of the number of diseases covered and total recommended vaccine doses, in contrast to 20 other developed nations.
The American Academy of Pediatrics has challenged this perspective, asserting that the existing U.S. vaccine recommendations are well-founded on robust evidence and closely resemble those of other developed countries. Dr. Michael Osterholm of the Vaccine Integrity Project cautioned that deviating from established vaccine recommendations could jeopardize children’s health.
“Disregarding vaccines that safeguard against influenza, hepatitis, and rotavirus, and altering the HPV vaccine recommendation without thorough public consultation on risks and benefits, may result in increased hospitalizations and preventable deaths among American children,” Osterholm cautioned.
